(1 - 6 von 16
)
EVOTEC ERWEITERT CRISPR-BASIERTES TECHNOLOGIEANGEBOT MIT LIZENZ VON...
www.dgap.de
EVOTEC ERWEITERT CRISPR-BASIERTES TECHNOLOGIEANGEBOT MIT LIZENZ VON ERS GENOMICS | Evotec SE | News | Nachricht | Mitteilung
Evotec expands CRISPR-based technology offering with licence from ERS...
www.evotec.com
For additional information please visit www.ersgenomics.com. MEDIA CONTACT ERS GENOMICS. MacDougall Biomedical Communications Mario Brkulj or Kara Mazey Direct: ...
Metactive Presents Results from Nonclinical Research Study Treating...
apnews.com
. or. Media: MacDougall Biomedical Communications. Kara Mazey,
CRISPR/Cas9 license for NMI TT Pharmaservices | C…er...
www.healthcapital.de
ERS Genomics Licenses CRISPR/Cas9 Genome Editing Patents to NMI and NMI TT Pharmaservices
ERS Genomics Licenses CRISPR Gene Editing Technology to DefiniGEN to...
apnews.com
· CONTACT: MacDougall Biomedical Communications for ERS Genomics Limited. Mario Brkulj or Kara Mazey, + or +
Evotec expands CRISPR-based technology offering with licence from ERS...
news.aptuit.com
Evotec expands CRISPR-based technology offering with licence from ERS genomics | press release
sortiert nach Relevanz / Datum